Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Non-Current Deferred Tax Liability (2017 - 2025)

Dr Reddys Laboratories (RDY) has 8 years of Non-Current Deferred Tax Liability data on record, last reported at $10.9 million in Q1 2024.

  • For Q1 2024, Non-Current Deferred Tax Liability rose 8.02% year-over-year to $10.9 million; the TTM value through Mar 2024 reached $10.9 million, up 8.02%, while the annual FY2024 figure was $11.0 million, 5.76% up from the prior year.
  • Non-Current Deferred Tax Liability reached $10.9 million in Q1 2024 per RDY's latest filing, up from $10.1 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $10.9 million in Q1 2024 and bottomed at $797944.4 in Q1 2022.
  • Average Non-Current Deferred Tax Liability over 5 years is $6.1 million, with a median of $4.6 million recorded in 2021.
  • Peak YoY movement for Non-Current Deferred Tax Liability: crashed 82.79% in 2022, then skyrocketed 1169.93% in 2023.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $3.8 million in 2020, then rose by 22.12% to $4.6 million in 2021, then crashed by 82.79% to $797944.4 in 2022, then surged by 1169.93% to $10.1 million in 2023, then rose by 8.02% to $10.9 million in 2024.
  • Per Business Quant database, its latest 3 readings for Non-Current Deferred Tax Liability were $10.9 million in Q1 2024, $10.1 million in Q1 2023, and $797944.4 in Q1 2022.